Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Unlocking New Approaches to Urolithiasis Management Via Nutraceuticals

Author(s): Ravindra Pal Singh, Anurag Mishra*, Shailendra Singh Chandel, Mohit Agarwal, Himmat Singh Chawra, Mithilesh Singh and Gaurav Dubey

Volume 25, Issue 9, 2024

Published on: 22 September, 2023

Page: [1124 - 1131] Pages: 8

DOI: 10.2174/1389201024666230821122416

Price: $65

conference banner
Abstract

Urolithiasis, commonly known as kidney stones, is characterized by the formation of hard deposits in the urinary tract. These stones can cause severe pain and discomfort, and their management typically involves a combination of medical interventions and lifestyle modifications. According to the literature, 30% and 50% of urolithiasis cases recur. Between 9 and 12% of persons in industrialised countries are predicted to have urolithiasis at some time. Due to the high frequency of stone formation, recurrent nature, and prevalence in adults, it has a significant impact on society, the person, and the health care system. Adopting the best prophylactic measures is crucial in light of these developments to decrease the impact of urolithiasis on individuals and society. In recent years, there has been growing interest in the potential role of nutraceuticals in the management of urolithiasis. Nutraceuticals, such as herbal extracts, vitamins, minerals, and probiotics, have gained recognition for their potential in promoting urinary health and reducing the risk of urolithiasis. These compounds can aid in various ways, including inhibiting crystal formation, enhancing urine pH balance, reducing urinary calcium excretion, and supporting kidney function. Additionally, nutraceuticals can help alleviate symptoms associated with urolithiasis, such as pain and inflammation. While medical interventions remain crucial, incorporating nutraceuticals into a comprehensive management plan can offer a holistic approach to urolithiasis, improving patient outcomes and quality of life. Therefore, nutraceuticals may be a desirable choice for treating and avoiding recurring urolithiasis for patients and medical professionals. Therefore, the present study has focused on nutraceuticals' role in preventing urolithiasis.

Keywords: Nutraceuticals, urolithiasis, polyphenols, antioxidant, vitamins, oxidative stress.

« Previous Next »
Graphical Abstract

[1]
Ahmad, M.; Butt, M.A.; Zhang, G.; Sultana, S.; Tariq, A.; Zafar, M. Bergenia ciliata: A comprehensive review of its traditional uses, phytochemistry, pharmacology and safety. Biomed. Pharmacother., 2018, 97, 708-721.
[2]
Lieske, J.C.; Walsh-Reitz, M.M.; Toback, F.G. Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am. J. Physiol., 1992, 262(4 Pt 2), F622-F630.
[PMID: 1566875]
[3]
Ahmad, M.; Shaheen, G.; Ahmad, S.; Akram, M.; Shah, S.M.A.; Zakki, S.A. Clinical efficacy of Unani medicine Renax for treatment of Urolithiasis. Pak. J. Pharm. Sci., 2017, 30(S5), 2003-2006.
[PMID: 29105635]
[4]
Ahmed, S.; Hasan, M.M.; Khan, H.; Mahmood, Z.A.; Patel, S. The mechanistic insight of polyphenols in calcium oxalate urolithiasis mitigation. Biomed. Pharmacother., 2018, 106(2018), 1292-1299.
[5]
Kataria, R.; Khatkar, A. Molecular docking of natural phenolic compounds for the screening of urease inhibitors. Curr. Pharm. Biotechnol., 2019, 20(5), 410-421.
[http://dx.doi.org/10.2174/1389201020666190409110948] [PMID: 30963969]
[6]
Akram, M.; Idrees, M. Progress and prospects in the management of kidney stones and developments in phyto-therapeutic modalities. Int. J. Immunopathol. Pharmacol., 2019, 33
[http://dx.doi.org/10.1177/2058738419848220] [PMID: 31046493]
[7]
Garg, S.; Roy, A. A current perspective of plants as an antibacterial agent: a review. Curr. Pharm. Biotechnol., 2020, 21(15), 1588-1602.
[http://dx.doi.org/10.2174/1389201021666200622121249] [PMID: 32568018]
[8]
Akter, S.; Netzel, M.; Tinggi, U.; Fletcher, M.; Osborne, S.; Sultanbawa, Y. Interactions between phytochemicals and minerals in terminalia ferdinandiana and implications for mineral bioavailability. Front. Nutr., 2020, 7, 598219.
[http://dx.doi.org/10.3389/fnut.2020.598219] [PMID: 33425972]
[9]
Chen, X.; Shen, L.; Gu, X.; Dai, X.; Zhang, L.; Xu, Y.; Zhou, P. High-dose supplementation with vitamin C--induced pediatric urolithiasis: The first case report in a child and literature review. Urology., 2014, 84(4), 922-924.
[http://dx.doi.org/10.1016/j.urology.2014.07.021] [PMID: 25260453]
[10]
Chewcharat, A.; Thongprayoon, C.; Vaughan, L.E.; Mehta, R.A.; Schulte, P.J.; O’Connor, H.M.; Lieske, J.C.; Taylor, E.N.; Rule, A.D. Dietary risk factors for incident and recurrent symptomatic kidney stones. Mayo Clin. Proc., 2022, 97(8), 1437-1448.
[http://dx.doi.org/10.1016/j.mayocp.2022.04.016] [PMID: 35933132]
[11]
Daly, R.M.; Ebeling, P.R. Is excess calcium harmful to health? Nutrients., 2010, 2(5), 505-522.
[http://dx.doi.org/10.3390/nu2050505] [PMID: 22254038]
[12]
Della Guardia, L.; Roggi, C.; Cena, H. Diet-induced acidosis and alkali supplementation. Int. J. Food Sci. Nutr., 2016, 67(7), 754-761.
[http://dx.doi.org/10.1080/09637486.2016.1198889] [PMID: 27338594]
[13]
Dissayabutra, T.; Kalpongnukul, N.; Chindaphan, K.; Srisa-art, M.; Ungjaroenwathana, W.; Kaewwongse, M.; Iampenkhae, K.; Tosukhowong, P. Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis. PLoS One, 2019, 14(3), e0213180.
[http://dx.doi.org/10.1371/journal.pone.0213180] [PMID: 30845174]
[14]
Eynard, A.R.; Navarro, A. Crosstalk among dietary polyunsaturated fatty acids, urolithiasis, chronic inflammation, and urinary tract tumor risk. Nutrition, 2013, 29(7-8), 930-938.
[http://dx.doi.org/10.1016/j.nut.2012.12.014] [PMID: 23594581]
[15]
Ferraro, P.M.; Curhan, G.C.; Gambaro, G.; Taylor, E.N. Total, dietary, and supplemental vitamin C intake and risk of incident kidney stones. Am. J. Kidney Dis., 2016, 67(3), 400-407.
[http://dx.doi.org/10.1053/j.ajkd.2015.09.005] [PMID: 26463139]
[16]
Barghouthy, Y.; Somani, B.K. Role of citrus fruit juices in prevention of kidney stone disease (KSD): A narrative review. Nutrients., 2021, 13(11), 4117.
[http://dx.doi.org/10.3390/nu13114117] [PMID: 34836376]
[17]
Baldini, N.; Torreggiani, E.; Roncuzzi, L.; Perut, F.; Zini, N.; Avnet, S. Exosome-like nanovesicles isolated from Citrus limon L. exert anti-oxidative effect. Curr. Pharm. Biotechnol., 2018, 19(11), 877-885.
[http://dx.doi.org/10.2174/1389201019666181017115755] [PMID: 30332948]
[18]
Ben Saad, A.; Tiss, M.; Keskes, H.; Chaari, A.; Sakavitsi, M.E.; Hamden, K.; Halabalaki, M.; Allouche, N. Antihyperlipidemic, antihyperglycemic, and liver function protection of Olea europaea var. meski stone and seed extracts: Lc-esi-hrms-based composition analysis. J. Diabetes Res., 2021, 2021, 1-10.
[http://dx.doi.org/10.1155/2021/6659415] [PMID: 33816636]
[19]
Borin, J.F.; Knight, J.; Holmes, R.P.; Joshi, S.; Goldfarb, D.S.; Loeb, S. Plant-based milk alternatives and risk factors for kidney stones and chronic kidney disease. J Ren Nutr., 2022, 32(2022), 363-365.
[20]
Gupta, G.; Dahiya, R.; Singh, Y.; Mishra, A.; Verma, A.; Gothwal, S.K.; Aljabali, A.A.A.; Dureja, H.; Prasher, P.; Negi, P.; Kapoor, D.N.; Goyal, R.; Tambuwala, M.M.; Chellappan, D.K.; Dua, K. Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease. Chem. Biol. Interact., 2020, 317, 108975.
[http://dx.doi.org/10.1016/j.cbi.2020.108975] [PMID: 32032593]
[21]
Cai, T.; Tiscione, D.; Puglisi, M.; Malossini, G.; Ruggera, L.; Verze, P.; Arcaniolo, D.; Palmieri, A. Phyllanthus niruri and Chrysanthellum americanum in association with potassium and magnesium citrates are able to prevent symptomatic episode in patients affected by recurrent urinary stones: A prospective study. Arch. Ital. Urol. Androl., 2021, 93(2), 184-188.
[22]
Gupta, G.; Chellappan, D.K.; Kikuchi, I.S.; Pinto, T.J.A.; Pabreja, K.; Agrawal, M.; Singh, Y.; Tiwari, J.; Dua, K. Nephrotoxicity in rats exposed to paracetamol: The protective role of moralbosteroid, a steroidal glycoside. J. Environ. Pathol. Toxicol. Oncol., 2017, 36(2), 113-119.
[http://dx.doi.org/10.1615/JEnvironPatholToxicolOncol.2017019457] [PMID: 29199592]
[23]
Chen, Y.; Ye, L.; Li, W.; Li, D.; Li, F. Hyperoside protects human kidney-2 cells against oxidative damage induced by oxalic acid. Mol. Med. Rep., 2018, 18(1), 486-494.
[http://dx.doi.org/10.3892/mmr.2018.8948] [PMID: 29750296]
[24]
Chen, Y.; Zhang, H.; Fan, W.; Mats, L.; Liu, R.; Deng, Z.; Tsao, R. Anti-Inflammatory Effect and Cellular Transport Mechanism of Phenolics from Common Bean (Phaseolus vulga L.) Milk and Yogurts in Caco-2 Mono- and Caco-2/EA.hy926 Co-Culture Models. J. Agric. Food Chem., 2021, 69(5), 1513-1523.
[http://dx.doi.org/10.1021/acs.jafc.0c06934] [PMID: 33497227]
[25]
Daniel, S.L.; Moradi, L.; Paiste, H.; Wood, K.D.; Assimos, D.G.; Holmes, R.P.; Nazzal, L.; Hatch, M.; Knight, J. Forty years of oxalobacter formigenes, a gutsy oxalate-degrading specialist. Appl. Environ. Microbiol., 2021, 87(18), e00544-e21.
[http://dx.doi.org/10.1128/AEM.00544-21] [PMID: 34190610]
[26]
Das, P.; Gupta, G.; Velu, V.; Awasthi, R.; Dua, K.; Malipeddi, H. Formation of struvite urinary stones and approaches towards the inhibition-A review. Biomed. Pharmacother., 2017, 96(2017), 361-370.
[27]
Das, P.; Kumar, K.; Nambiraj, A.; Rajan, R.; Awasthi, R.; Dua, K.; M, H. Potential therapeutic activity of Phlogacanthus thyrsiformis Hardow (Mabb) flower extract and its biofabricated silver nanoparticles against chemically induced urolithiasis in male Wistar rats. Int. J. Biol. Macromol., 2017, 103, 621-629.
[http://dx.doi.org/10.1016/j.ijbiomac.2017.05.096] [PMID: 28528955]
[28]
De Bellis, R.; Piacentini, M.P.; Meli, M.A.; Mattioli, M.; Menotta, M.; Mari, M.; Valentini, L.; Palomba, L.; Desideri, D.; Chiarantini, L. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism. PLoS. One., 2019, 14(6), e0218734.
[http://dx.doi.org/10.1371/journal.pone.0218734] [PMID: 31238335]
[29]
Dinnimath, B.M.; Jalalpure, S.S.; Patil, U.K. Antiurolithiatic activity of natural constituents isolated from Aerva lanata. J. Ayurveda Integr. Med., 2017, 8(4), 226-232.
[http://dx.doi.org/10.1016/j.jaim.2016.11.006] [PMID: 29169771]
[30]
Divya, G.; Albert, A.; Singab, A.N.B.; Ayoub, I.M.; Al-Sayed, E.; Paul, E.; Manoharan, K.; Saso, L.; Selvam, G.S. Renoprotective effect of tectorigenin glycosides isolated from Iris spuria L. (Zeal) against hyperoxaluria and hyperglycemia in NRK-49Fcells. Nat. Prod. Res., 2021, 35(6), 1029-1034.
[http://dx.doi.org/10.1080/14786419.2019.1613396] [PMID: 31135219]
[31]
Emiliani, E.; Jara, A.; Kanashiro, A.K. Phytotherapy and herbal medicines for kidney stones. Curr. Drug Targets, 2020, 22(1), 22-30.
[http://dx.doi.org/10.2174/1389450121666200929115555] [PMID: 32990535]
[32]
Fan, Q.X.; Gong, S.Q.; Hong, X.Z.; Feng, X.M.; Zhang, F.J. Clinical-grade Garcinia cambogia extract dissolves calcium oxalate crystals in Drosophila kidney stone models. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(11), 6434-6445.
[PMID: 32572941]
[33]
Harvey, N.C.; Biver, E.; Kaufman, J.M.; Bauer, J.; Branco, J.; Brandi, M.L.; Bruyère, O.; Coxam, V.; Cruz-Jentoft, A.; Czerwinski, E.; Dimai, H.; Fardellone, P.; Landi, F.; Reginster, J.Y.; Dawson-Hughes, B.; Kanis, J.A.; Rizzoli, R.; Cooper, C. The role of calcium supplementation in healthy musculoskeletal ageing: An expert consensus meeting of the european society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporos. Int., 2017, 28(2017), 447-462.
[34]
Fayez Hass, N.; Khaled Ibr, M.; Yousef El, S.; Abd Allah, H. Characterization of biofilm producer nanobacteria isolated from kidney stones of some egyptian patients. Pak. J. Biol. Sci., 2021, 24(9), 953-970.
[http://dx.doi.org/10.3923/pjbs.2021.953.970] [PMID: 34585548]
[35]
Gautam, M.; Datt, N.; Chahota, R.K. Assessment of calcium oxalate crystal inhibition potential, antioxidant activity and amino acid profiling in horse gram (Macrotyloma uniflorum): High altitude farmer's varieties. 3 Biotech., 2020, 10(2020), 402.
[36]
Ghali, F.; Dagrosa, L.M.; Moses, R.A.; Ursiny, M.; Eisner, B.H.; Jr, V.M.P. Changing incidence of factitious renal stone disease. Clin. Nephrol., 2018, 90(2), 102-105.
[http://dx.doi.org/10.5414/CN109331] [PMID: 29882511]
[37]
Gohain, A.; Sharma, A.; Gogoi, H.J.; Cooper, R.; Kaur, R.; Nayik, G.A.; Shaikh, A.M.; Kovács, B.; Areche, F.O.; Ansari, M.J.; Alabdallah, N.M.; Al-Farga, A. Bergenia pacumbis (Buch.-Ham. ex D.Don) C.Y.Wu & J.T.Pan: A comprehensive review on traditional uses, phytochemistry and pharmacology; Plants: Basel, Switzerland, 2022, p. 11.
[38]
Shahcheraghi, S.H.; Aljabali, A.A.A.; Al Zoubi, M.S.; Mishra, V.; Charbe, N.B.; Haggag, Y.A.; Shrivastava, G.; Almutary, A.G.; Alnuqaydan, A.M.; Barh, D.; Dua, K.; Chellappan, D.K.; Gupta, G.; Lotfi, M.; Serrano-Aroca, Á.; Bahar, B.; Mishra, Y.K.; Takayama, K.; Panda, P.K.; Bakshi, H.A.; Tambuwala, M.M. Overview of key molecular and pharmacological targets for diabetes and associated diseases. Life. Sci., 2021, 278, 119632.
[http://dx.doi.org/10.1016/j.lfs.2021.119632] [PMID: 34019900]
[39]
Gupta, M.; Bhayana, S.; Sikka, S. Role of urinary inhibitors and promoters in calcium oxalate crystallisation. Int. J. Res. Pharm. Sci., 2011, 1(4)
[40]
Haghighatdoost, F.; Sadeghian, R.; Abbasi, B. The associations between tea and coffee drinking and risk of calcium-oxalate renal stones. Plant Foods Hum. Nutr., 2021, 76(4), 516-522.
[http://dx.doi.org/10.1007/s11130-021-00933-4] [PMID: 34735676]
[41]
Horby, P.; Lim, W.S.; Emberson, J.R.; Mafham, M.; Bell, J.L.; Linsell, L.; Staplin, N.; Brightling, C.; Ustianowski, A.; Elmahi, E.; Prudon, B.; Green, C.; Felton, T.; Chadwick, D.; Rege, K.; Fegan, C.; Chappell, L.C.; Faust, S.N.; Jaki, T.; Jeffery, K.; Montgomery, A.; Rowan, K.; Juszczak, E.; Baillie, J.K.; Haynes, R.; Landray, M.J. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med., 2021, 384(8), 693-704.
[http://dx.doi.org/10.1056/NEJMoa2021436] [PMID: 32678530]
[42]
Horby, P.; Mafham, M.; Linsell, L.; Bell, J.L.; Staplin, N.; Emberson, J.R.; Wiselka, M.; Ustianowski, A.; Elmahi, E.; Prudon, B.; Whitehouse, T.; Felton, T.; Williams, J.; Faccenda, J.; Underwood, J.; Baillie, J.K.; Chappell, L.C.; Faust, S.N.; Jaki, T.; Jeffery, K.; Lim, W.S.; Montgomery, A.; Rowan, K.; Tarning, J.; Watson, J.A.; White, N.J.; Juszczak, E.; Haynes, R.; Landray, M.J. Effect of hydroxychloroquine in hospitalized patients with covid-19. N. Engl. J. Med., 2020, 383(21), 2030-2040.
[http://dx.doi.org/10.1056/NEJMoa2022926] [PMID: 33031652]
[43]
Hosseini, A.; Mirzaee, F.; Davoodi, A.; Bakhshi, J.H.; Azadbakh, M. The traditional medicine aspects, biological activity and phytochemistry of Arnebia spp. Med. Glas., 2018, 15, 1-9.
[44]
Jiang, K.; Tang, K.; Liu, H.; Xu, H.; Ye, Z.; Chen, Z. Ascorbic acid supplements and kidney stones incidence among men and women: A systematic review and meta-analysis. Urol. J., 2019, 16(2), 115-120.
[PMID: 30178451]
[45]
Johnson, K.C.; Pittas, A.G.; Margolis, K.L.; Peters, A.L.; Phillips, L.S.; Vickery, E.M.; Nelson, J.; Sheehan, P.R.; Reboussin, D.; Malozowski, S.; Chatterjee, R.; Pittas, A.G.; Brodsky, I.; Ceglia, L.; Chadha, C.; Chatterjee, R.; Dawson-Hughes, B.; Desouza, C.; Dolor, R.; Foreyt, J.; Ghazi, A.; Hsia, D.S.; Johnson, K.C.; Kashyap, S.R.; Kim, S.; LeBlanc, E.S.; Lewis, M.R.; Liao, E.; Malozowski, S.; Neff, L.M.; O’Neil, P.; Park, J.; Peters, A.; Phillips, L.S.; Pratley, R.; Raskin, P.; Rasouli, N.; Robbins, D.; Rosen, C.; Aroda, V.R.; Sheehan, P.; Staten, M.A.; Ware, J.H.; Knowler, W.C. Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes. Eur. J. Clin. Nutr., 2022, 76(8), 1117-1124.
[http://dx.doi.org/10.1038/s41430-022-01068-8] [PMID: 35140313]
[46]
Kahwati, L.C.; Weber, R.P.; Pan, H.; Gourlay, M.; LeBlanc, E.; Coker-Schwimmer, M.; Viswanathan, M.; Vitamin, D. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults. JAMA., 2018, 319(15), 1600-1612.
[http://dx.doi.org/10.1001/jama.2017.21640] [PMID: 29677308]
[47]
Huang, F.; Sun, X.Y.; Ouyang, J.M. Preparation and characterization of selenized Astragalus polysaccharide and its inhibitory effect on kidney stones. Mater. Sci. Eng. C, 2020, 110, 110732.
[http://dx.doi.org/10.1016/j.msec.2020.110732] [PMID: 32204043]
[48]
Huang, J.L.; Mo, Z.Y.; Li, Z.Y.; Liang, G.Y.; Liu, H.L.; Aschner, M.; Ou, S.Y.; Zhou, B.; Chen, Z.M.; Jiang, Y.M. Association of lead and cadmium exposure with kidney stone incidence: A study on the non-occupational population in Nandan of China. J. Trace Elem. Med. Biol., 2021, 68, 126852.
[49]
Pattanayak, P.; Singh, S.K.; Gulati, M.; Vishwas, S.; Kapoor, B.; Chellappan, D.K.; Anand, K.; Gupta, G.; Jha, N.K.; Gupta, P.K.; Prasher, P.; Dua, K.; Dureja, H.; Kumar, D.; Kumar, V. Microfluidic chips: Recent advances, critical strategies in design, applications and future perspectives. Microfluid. Nanofluidics, 2021, 25(12), 99.
[http://dx.doi.org/10.1007/s10404-021-02502-2] [PMID: 34720789]
[50]
Karam, A.; Mjaess, G.; Younes, H.; Aoun, F. Increase in urolithiasis prevalence due to vitamins C and D supplementation during the COVID-19 pandemic. J. Public Health., 2022, 44(4), e625-e626.
[http://dx.doi.org/10.1093/pubmed/fdab328] [PMID: 34486059]
[51]
Kim, D.; Rimer, J.D.; Asplin, J.R. Hydroxycitrate: A potential new therapy for calcium urolithiasis. Urolithiasis, 2019, 47(4), 311-320.
[http://dx.doi.org/10.1007/s00240-019-01125-1] [PMID: 30915494]
[52]
Kozyrakis, D.; Paridis, D.; Karatzas, A.; Soukias, G.; Dailiana, Z. Do calcium supplements predispose to urolithiasis? Curr. Urol. Rep., 2017, 18(3), 17.
[http://dx.doi.org/10.1007/s11934-017-0668-9] [PMID: 28233226]
[53]
Leaf, D.E. Calcium kidney stones. N. Engl. J. Med., 2010, 363(25), 2470-2471.
[http://dx.doi.org/10.1056/NEJMc1011349] [PMID: 21158674]
[54]
Letavernier, E.; Daudon, M.; Vitamin, D. Vitamin D, hypercalciuria and kidney stones. Nutrients, 2018, 10(3), 366.
[http://dx.doi.org/10.3390/nu10030366] [PMID: 29562593]
[55]
Levenson, D.I.; Bockman, R.S. A review of calcium preparations. Nutr. Rev., 1994, 52(7), 221-232.
[http://dx.doi.org/10.1111/j.1753-4887.1994.tb01427.x] [PMID: 8090373]
[56]
Mocanu, C.A.; Simionescu, T.P.; Mocanu, A.E.; Garneata, L. Plant-based versus animal-based low protein diets in the management of chronic kidney disease. Nutrients., 2021, 13(11), 3721.
[57]
Attalla, K.; De, S.; Sarkissian, C.; Monga, M. Seasonal variations in urinary calcium, volume, and vitamin d in kidney stone formers. Int. Braz. J. Urol., 2018, 44, 947-951.
[58]
Bargagli, M.; Ferraro, P.M.; Vittori, M.; Lombardi, G.; Gambaro, G.; Somani, B. Calcium and vitamin D supplementation and their association with kidney stone disease: A narrative review. Nutrients., 2021, 13(12), 4363.
[http://dx.doi.org/10.3390/nu13124363] [PMID: 34959915]
[59]
Gupta, G.; de Jesus Andreoli Pinto, T.; Chellappan, D.K.; Mishra, A.; Malipeddi, H.; Dua, K. A clinical update on metformin and lung cancer in diabetic patients. Panminerva Med., 2018, 60(2), 70-75.
[http://dx.doi.org/10.23736/S0031-0808.18.03394-3] [PMID: 29370676]
[60]
Brogan, M.; Astor, B.C.; Melamed, M.L. Vitamin D in chronic kidney disease. Curr. Opin. Nephrol. Hypertens., 2020, 29(2), 243-247.
[http://dx.doi.org/10.1097/MNH.0000000000000591] [PMID: 31996592]
[61]
Eskandarifar, A.; Roshani, D.; Tabarkhun, A.; Ataee, E. Assessment of serum level of vitamin D in infants with nephrolithiasis. Iran. J. Kidney Dis., 2021, 1(2), 116-120.
[PMID: 33764322]
[62]
Gillion, V.; Saussez, T.P.; Van Nieuwenhove, S.; Jadoul, M. Extremely rapid stone formation in cystinuria: Look out for dietary supplements! Clin. Kidney J., 2021, 14(6), 1694-1696.
[http://dx.doi.org/10.1093/ckj/sfab013] [PMID: 34084466]
[63]
Guerra, A.; Ticinesi, A.; Allegri, F.; Nouvenne, A.; Prati, B.; Pinelli, S.; Merli, R.; Tana, C.; Lauretani, F.; Aloe, R.; Borghi, L.; Meschi, T. Insights about urinary hippuric and citric acid as biomarkers of fruit and vegetable intake in patients with kidney stones: The role of age and sex. Nutrition., 2019, 59, 83-89.
[http://dx.doi.org/10.1016/j.nut.2018.07.112] [PMID: 30471528]
[64]
Guzel, A.; Yunusoglu, S.; Calapoglu, M.; Candan, I.A.; Onaran, I.; Oncu, M.; Ergun, O.; Oksay, T. Protective effects of quercetin on oxidative stress-induced tubular epithelial damage in the experimental rat hyperoxaluria model. Medicina., 2021, 57(6), 566.
[http://dx.doi.org/10.3390/medicina57060566] [PMID: 34204866]
[65]
Kanlaya, R.; Thongboonkerd, V. Protective effects of epigallocatechin-3-gallate from green tea in various kidney diseases. Adv. Nutr., 2019, 10(1), 112-121.
[66]
Li, S.; Macaringue, E.G.J.; Zhou, D.; Shi, P.; Tang, W.; Gong, J. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs. J. Ethnopharmacol., 2022, 284, 114733.
[http://dx.doi.org/10.1016/j.jep.2021.114733] [PMID: 34644589]
[67]
Li, Z.; Chang, L.; Ren, X.; Hu, Y.; Chen, Z. Modulation of rat kidney stone crystallization and the relative oxidative stress pathway by green tea polyphenol. ACS Omega., 2021, 6(2), 1725-1731.
[http://dx.doi.org/10.1021/acsomega.0c05903] [PMID: 33490831]
[68]
Rode, J.; Bazin, D.; Dessombz, A.; Benzerara, Y.; Letavernier, E.; Tabibzadeh, N.; Hoznek, A.; Tligui, M.; Traxer, O.; Daudon, M.; Haymann, J.P. Daily green tea infusions in hypercalciuric renal stone patients: No evidence for increased stone risk factors or oxalate-dependent stones. Nutrients., 2019, 11(2), 256.
[http://dx.doi.org/10.3390/nu11020256] [PMID: 30678344]
[69]
Yasir, F.; Wahab, A.; Choudhary, M.I. Protective effect of dietary polyphenol caffeic acid on ethylene glycol-induced kidney stones in rats. Urolithiasis., 2018, 46(2), 157-166.
[http://dx.doi.org/10.1007/s00240-017-0982-1] [PMID: 28616648]
[70]
Ye, Q.L.; Wang, D.M.; Wang, X.; Zhang, Z.Q.; Tian, Q.X.; Feng, S.Y.; Zhang, Z.H.; Yu, D.X.; Ding, D.M.; Xie, D.D. Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury. Chem. Biol. Interact., 2021, 347, 109605.
[http://dx.doi.org/10.1016/j.cbi.2021.109605] [PMID: 34333021]
[71]
Zeng, X.; Xi, Y.; Jiang, W. Protective roles of flavonoids and flavonoid-rich plant extracts against urolithiasis: A review. Crit. Rev. Food Sci. Nutr., 2019, 59(13), 2125-2135.
[http://dx.doi.org/10.1080/10408398.2018.1439880] [PMID: 29432040]
[72]
Lewandowski, S.; Rodgers, A.L. Idiopathic calcium oxalate urolithiasis: Risk factors and conservative treatment. Clin. Chim. Acta., 2004, 345(1-2), 17-34.
[73]
Li, K.; Wang, X.F.; Li, D.Y.; Chen, Y.C.; Zhao, L.J.; Liu, X.G.; Guo, Y.F.; Shen, J.; Lin, X.; Deng, J.; Zhou, R.; Deng, H.W. The good, the bad, and the ugly of calcium supplementation: A review of calcium intake on human health. Clin. Interv. Aging, 2018, 13, 2443-2452.
[http://dx.doi.org/10.2147/CIA.S157523] [PMID: 30568435]
[74]
Lin, B.B.; Lin, M.E.; Huang, R.H.; Hong, Y.K.; Lin, B.L.; He, X.J. Dietary and lifestyle factors for primary prevention of nephrolithiasis: A systematic review and meta-analysis. BMC Nephrol., 2020, 21(1), 267.
[http://dx.doi.org/10.1186/s12882-020-01925-3] [PMID: 32652950]
[75]
Madden, E.; McLachlan, C.; Oketch-Rabah, H.; Calderón, A.I. Safety of cranberry: Evaluation of evidence of kidney stone formation and botanical drug-interactions. Planta Med., 2021, 87(10/11), 803-817.
[http://dx.doi.org/10.1055/a-1497-6241] [PMID: 34015833]
[76]
Massey, L. Magnesium therapy for nephrolithiasis. Magnes. Res., 2005, 18(2), 123-126.
[PMID: 16100850]
[77]
Mehta, M.; Goldfarb, D.S.; Nazzal, L. The role of the microbiome in kidney stone formation. Int. J. Surg., 2016, 36(Pt D), 607-612.
[http://dx.doi.org/10.1016/j.ijsu.2016.11.024] [PMID: 27847292]
[78]
Messa, P.; Castellano, G.; Vettoretti, S.; Alfieri, C.M.; Giannese, D.; Panichi, V.; Cupisti, A. Vitamin D and calcium supplementation and urolithiasis: A controversial and multifaceted relationship. Nutrients., 2023, 15(7), 1724.
[http://dx.doi.org/10.3390/nu15071724] [PMID: 37049567]
[79]
Negri, A.L. The role of zinc in urinary stone disease. Int. Urol. Nephrol., 2018, 50(5), 879-883.
[http://dx.doi.org/10.1007/s11255-017-1784-7] [PMID: 29344880]
[80]
Nirumand, M.; Hajialyani, M.; Rahimi, R.; Farzaei, M.; Zingue, S.; Nabavi, S.; Bishayee, A. Dietary plants for the prevention and management of kidney stones: Preclinical and clinical evidence and molecular mechanisms. Int. J. Mol. Sci., 2018, 19(3), 765.
[http://dx.doi.org/10.3390/ijms19030765] [PMID: 29518971]
[81]
Oswal, M.; Varghese, R.; Zagade, T.; Dhatrak, C.; Sharma, R.; Kumar, D. Dietary supplements and medicinal plants in urolithiasis: diet, prevention, and cure. J. Pharm. Pharmacol., 2023, 75(6), 719-745.
[http://dx.doi.org/10.1093/jpp/rgac092] [PMID: 37130140]
[82]
Palermo, A.; Naciu, A.M.; Tabacco, G.; Manfrini, S.; Trimboli, P.; Vescini, F.; Falchetti, A. Calcium citrate: From biochemistry and physiology to clinical applications. Rev. Endocr. Metab. Disord., 2019, 20(3), 353-364.
[http://dx.doi.org/10.1007/s11154-019-09520-0] [PMID: 31643038]
[83]
Peerapen, P.; Thongboonkerd, V. Kidney stone prevention. Adv. Nutr., 2023, 14, 555-569.
[84]
Preminger, G.M. Oxaluria--the neglected stepchild of nephrolithiasis? J. Urol., 2003, 170(2), 402-403.
[http://dx.doi.org/10.1097/01.ju.0000077445.02082.3d] [PMID: 12853785]
[85]
Prentice, R.L.; Pettinger, M.B.; Jackson, R.D.; Wactawski-Wende, J.; Lacroix, A.Z.; Anderson, G.L.; Chlebowski, R.T.; Manson, J.E.; Van Horn, L.; Vitolins, M.Z.; Datta, M.; LeBlanc, E.S.; Cauley, J.A.; Rossouw, J.E. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos. Int., 2013, 24, 567-580.
[86]
Prezioso, D.; Strazzullo, P.; Lotti, T.; Bianchi, G.; Borghi, L.; Caione, P.; Carini, M.; Caudarella, R.; Ferraro, M.; Gambaro, G.; Gelosa, M.; Guttilla, A.; Illiano, E.; Martino, M.; Meschi, T.; Messa, P.; Miano, R.; Napodano, G.; Nouvenne, A.; Rendina, D.; Rocco, F.; Rosa, M.; Sanseverino, R.; Salerno, A.; Spatafora, S.; Tasca, A.; Ticinesi, A.; Travaglini, F.; Trinchieri, A.; Vespasiani, G.; Zattoni, F. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch. Ital. Urol. Androl., 2015, 87(2), 105-120.
[87]
Prochaska, M. Bisphosphonates and management of kidney stones and bone disease. Curr. Opin. Nephrol. Hypertens., 2021, 30(2), 184-189.
[http://dx.doi.org/10.1097/MNH.0000000000000682] [PMID: 33394731]
[88]
Ambrogi, V.; Bottacini, F.; O’Callaghan, J.; Casey, E.; van Breen, J.; Schoemaker, B.; Cao, L.; Kuipers, B.; O’Connell Motherway, M.; Schoterman, M.; van Sinderen, D. Infant-associated bifidobacterial β-galactosidases and their ability to synthesize galacto-oligosaccharides. Front. Microbiol., 2021, 12, 662959.
[http://dx.doi.org/10.3389/fmicb.2021.662959] [PMID: 34012427]
[89]
Borges, D.; Guzman-Novoa, E.; Goodwin, P.H. Effects of prebiotics and probiotics on honey bees (Apis mellifera) infected with the microsporidian parasite nosema ceranae. Microorganisms., 2021, 9(3), 481.
[http://dx.doi.org/10.3390/microorganisms9030481] [PMID: 33668904]
[90]
Cao, A. The last secret of protein folding: the real relationship between long-range interactions and local structures. Protein J., 2020, 39(5), 422-433.
[http://dx.doi.org/10.1007/s10930-020-09925-w] [PMID: 33040262]
[91]
Chen, Y.; Wang, Q.; Gao, W.; Ma, B.; Xue, D.; Hao, C. Changes and correlations of the intestinal flora and liver metabolite profiles in mice with gallstones. Front. Physiol., 2021, 12, 716654.
[http://dx.doi.org/10.3389/fphys.2021.716654] [PMID: 34489732]
[92]
Emami, N.K.; Dalloul, R.A. Centennial review: Recent developments in host-pathogen interactions during necrotic enteritis in poultry. Poult. Sci., 2021, 100(9), 101330.
[http://dx.doi.org/10.1016/j.psj.2021.101330] [PMID: 34280643]
[93]
Yang, Y.; Ma, Y.; Hu, X.; Cui, S.W.; Zhang, T.; Miao, M. Reuteransucrase-catalytic kinetic modeling and functional characteristics for novel prebiotic gluco-oligomers. Food Funct., 2020, 11(8), 7037-7047.
[http://dx.doi.org/10.1039/D0FO00225A] [PMID: 32812985]
[94]
Gaylor, M.O.; Miro, P.; Vlaisavljevich, B.; Kondage, A.A.S.; Barge, L.M.; Omran, A.; Videau, P.; Swenson, V.A.; Leinen, L.J.; Fitch, N.W.; Cole, K.L.; Stone, C.; Drummond, S.M.; Rageth, K.; Dewitt, L.R.; González Henao, S.; Karanauskus, V. Plausible emergence and self assembly of a primitive phospholipid from reduced phosphorus on the primordial earth. Orig. Life Evol. Biosph., 2021, 51, 185-213.
[95]
Stepanova, N.; Akulenko, I.; Serhiichuk, T.; Dovbynchuk, T.; Savchenko, S.; Tolstanova, G. Synbiotic supplementation and oxalate homeostasis in rats: focus on microbiota oxalate-degrading activity. Urolithiasis., 2022, 50(3), 249-258.
[http://dx.doi.org/10.1007/s00240-022-01312-7] [PMID: 35129638]
[96]
Sumida, Y.; Yoneda, M.; Toyoda, H.; Yasuda, S.; Tada, T.; Hayashi, H.; Nishigaki, Y.; Suzuki, Y.; Naiki, T.; Morishita, A.; Tobita, H.; Sato, S.; Kawabe, N.; Fukunishi, S.; Ikegami, T.; Kessoku, T.; Ogawa, Y.; Honda, Y.; Nakahara, T.; Munekage, K.; Ochi, T.; Sawada, K.; Takahashi, A.; Arai, T.; Kogiso, T.; Kimoto, S.; Tomita, K.; Notsumata, K.; Nonaka, M.; Kawata, K.; Takami, T.; Kumada, T.; Tomita, E.; Okanoue, T.; Nakajima, A. Common drug pipelines for the treatment of diabetic nephropathy and hepatopathy: Can we kill two birds with one stone? Int. J. Mol. Sci., 2020, 21(14), 4939.
[97]
Ke, A.; Parreira, V.R.; Farber, J.M.; Goodridge, L. Selection of a potential synbiotic against cronobacter sakazakii. J. Food Prot., 2022, 85(9), 1240-1248.
[http://dx.doi.org/10.4315/JFP-22-048] [PMID: 35435968]
[98]
Klassen, S.S.; VanBlyderveen, W.; Eccles, L.; Kelly, P.G.; Borges, D.; Goodwin, P.H.; Petukhova, T.; Wang, Q.; Guzman-Novoa, E. Nosema ceranae infections in honey bees (apis mellifera) treated with pre/probiotics and impacts on colonies in the field. Vet. Sci., 2021, 8(6), 107.
[http://dx.doi.org/10.3390/vetsci8060107] [PMID: 34200566]
[99]
Mithul, A.S.; Wichienchot, S.; Tsao, R.; Ramakrishnan, S.; Chakkaravarthi, S. Role of dietary polyphenols on gut microbiota, their metabolites and health benefits. Food Res Int., 2021, 142(2021), 110189.
[100]
Pastorek, A.; Clark, V.H.J.; Yurchenko, S.N.; Ferus, M.; Civiš, S. New physical insights: Formamide discharge decomposition and the role of fragments in the formation of large biomolecules. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2022, 278, 121322.
[http://dx.doi.org/10.1016/j.saa.2022.121322] [PMID: 35537261]

Rights & Permissions Print Cite
Article Metrics
15
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy